The cyrano nose: refinements in surgical technique and treatment approach to hemangiomas of the nasal tip
10.1097/prs.0b013e3181ea44c5 · doi-reference
Complicated infantile hemangioma of the lip: outcomes of early versus late resection
10.1097/prs.0b013e31827c6fe2 · doi-reference
Resection of amblyogenic periocular hemangiomas: indications and outcomes
10.1097/prs.0b013e3181c49708 · doi-reference
Indications for surgical resection of complicated infantile hemangiomas in the β-blocker’s era: a single-institution experience from a retrospective cohort study
10.1097/js9.0000000000000324 · doi-reference
Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid
10.1007/s00431-018-3290-z · doi-reference
Has propranolol eradicated the need for surgery in the management of infantile hemangioma?
10.1097/prs.0000000000011532 · doi-reference
Propranolol versus prednisone in the treatment of infantile hemangiomas: a retrospective comparative study
10.1111/j.1525-1470.2011.01551.x · doi-reference
Propranolol vs. steroids in the treatment of infantile hemangiomas: a meta-analysis
10.3892/mco.2021.2318 · doi-reference
A meta-analysis on the effectiveness of propranolol for the treatment of infantile airway haemangiomas
10.1016/j.ijporl.2011.01.028 · doi-reference
Higher doses of oral propranolol for resistant infantile haemangio-mas
10.2340/actadv.v106.43152 · doi-reference
Worsening ulceration of infantile hemangioma after initiation or escalation of propranolol
10.1111/pde.14933 · doi-reference
Initiation and use of propranolol for infantile hemangioma: report of a consensus conference
10.1542/peds.2012-1691 · doi-reference
Rebound growth of infantile hemangiomas after propranolol therapy
10.1542/peds.2015-1754 · doi-reference
Severe hypoglycemia in propranolol treatment for infantile hemangiomas
10.1111/ped.15278 · doi-reference
Beta-blockers as therapy for infantile hemangiomas
10.1055/s-0034-1376259 · doi-reference
Propranolol and infantile hemangiomas four years later: a systematic review
10.1111/pde.12089 · doi-reference
Propranolol therapy in infantile hemangioma: it is not just about the beta
10.1097/prs.0000000000007699 · doi-reference
Propranolol targets hemangioma stem cells via cAMP and mitogen-activated protein kinase regulation
10.5966/sctm.2015-0076 · doi-reference
Propranolol promotes accelerated and dysregulated adipogenesis in hemangioma stem cells
10.1097/sap.0000000000000272 · doi-reference
Propranolol accelerates adipogenesis in hemangioma stem cells and causes apoptosis of hemangioma endothelial cells
10.1097/prs.0b013e318267d3db · doi-reference
Propranolol induces regression of hemangioma cells through HIF-1α-Mediated inhibition of VEGF-A
10.1097/sla.0b013e318254ce7a · doi-reference
A randomized, controlled trial of oral propranolol in infantile hemangioma
10.1056/nejmoa1404710 · doi-reference
Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial
10.1001/jamaoto.2013.6723 · doi-reference
Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis
10.1097/prs.0b013e31827c6fab · doi-reference
Effect of propranolol vs prednisolone vs propranolol with prednisolone in the management of infantile hemangioma: a randomized controlled study
10.1016/j.jpedsurg.2013.08.020 · doi-reference
Efficacy and safety of propranolol for the treatment of infantile hemangioma: a presentation of ninety-nine cases
10.1159/000351557 · doi-reference
Propranolol reduces infantile hemangioma volume and vessel density
10.1177/0194599812451570 · doi-reference
A randomized controlled trial of propranolol for infantile hemangiomas
10.1542/peds.2010-0029 · doi-reference
Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study
10.1111/j.1525-1470.2010.01379.x · doi-reference
Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center
10.1002/lary.20807 · doi-reference
Propranolol for severe hemangiomas of infancy
10.1056/nejmc0708819 · doi-reference
Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy
10.1016/s0022-3476(98)70034-4 · doi-reference
Infants with Kasabach-Merritt syndrome do not have ‘true’ hemangiomas
10.1016/s0022-3476(97)70249-x · doi-reference
Additional corrections: interferon for hemangiomas of infancy
10.1056/nejm199508313330913 · doi-reference
Interferon alpha therapy of haemangiomas in newborns and infants
10.1111/j.1365-2141.1991.tb08123.x · doi-reference
Treatment of hemangioendotheliomas with alpha-interferon
10.1016/s0140-6736(89)90694-6 · doi-reference
Treatment of pulmonary hemangiomatosis with recombinant interferon Alfa-2a
10.1056/nejm198905043201807 · doi-reference
Interferon Alfa-2a therapy for life-threatening hemangiomas of infancy
10.1056/nejm199205283262203 · doi-reference
“Management of problematic infantile hemangioma using intralesional triamcinolone: efficacy and safety in 100 infants.”
10.1016/j.bjps.2014.07.009 · doi-reference
Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases
10.1016/s0022-3468(00)90205-7 · doi-reference
